Late Breaking Abstract - The “one airway, one disease” concept at the light of Th2 inflammation

L. Giovannini-Chami (Nice, France)

Source: International Congress 2017 – Gene signatures in bronchial diseases
Session: Gene signatures in bronchial diseases
Session type: Poster Discussion
Number: 4938
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Giovannini-Chami (Nice, France). Late Breaking Abstract - The “one airway, one disease” concept at the light of Th2 inflammation. 4938

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The “one airway, one disease” concept in light of Th2 inflammation
Source: Eur Respir J, 52 (4) 1800437; 10.1183/13993003.00437-2018
Year: 2018



Late Breaking Abstract - IL-33 drives influenza-induced exacerbations of asthma by halting anti-viral and Th1 responses
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017

Late Breaking Abstract - B cell adaptive immune profile in emphysema-predominant COPD
Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2019



Late Breaking Abstract: A role for IL-25 as ‘initiator‘ in Th2 driven inflammation is restricted to IL-5 high Th2 patients
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010

Late Breaking Abstract - The inflammasome cluster is linked with airway NETosis in COPD
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021



Late Breaking Abstract - GATA-3 in lung CD4+T cells drives Interleukin-10 deficiency-induced lung inflammation in asthma
Source: Virtual Congress 2020 – New insights into asthma immunology: in mouse and men
Year: 2020




Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


Late Breaking Abstract - Formaldehyde inhalation impairs immune system and may affects severity of allergic disease
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017

Late Breaking Abstract - Hypoxia dampens the allergen-dependent adaptive immune response and ameliorates allergic asthma in vivo
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021


Late Breaking Abstract - Biological determinants of sputum rheology in chronic airway diseases
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Interleukin-33 and Th2 cytokines correlate in acute asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016

Late Breaking Abstract - The impact of treatment with mepolizumab on airway remodeling in patients with severe eosinophilic asthma.
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Late Breaking Abstract - Hypoxia-induced responses to mimic ongoing remodelling processes in chronic lung diseases
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020


Late Breaking Abstract - Gender and asthma: Gender-dependent effects of obesity on allergic pulmonary inflammation
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018




Late Breaking Abstract: IL-17 inhibits IL-23 release during airway inflammation
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010


Late Breaking Abstract - Early response to benralizumab in Canadians with severe eosinophilic asthma
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Late Breaking Abstract - Effect of timapiprant, a DP2 antagonist, on airway inflammation in severe eosinophilic asthma
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma
Year: 2019




Late Breaking Abstract - A GATA3-specific DNAzyme attenuates sputum eosinophilia in COPD patients with eosinophilic airway inflammation
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017

Peripheral blood Th9 cells and IL-9 level in asthma patients with early and dual asthmatic response
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015